Voice Therapy With a Semi-occluded Vocal Tract

Sponsor
University Ghent (Other)
Overall Status
Completed
CT.gov ID
NCT06137131
Collaborator
Research Foundation Flanders (Other)
70
1
4
17.2
4.1

Study Details

Study Description

Brief Summary

  1. The first objective of this research is to investigate the immediate effects of three semi-occluded vocal tract (SOVT) exercises (straw phonation in air, straw phonation in 2cm water, and straw phonation in 5cm water) on (supra)glottic activity of vocally healthy participants and patients with voice disorders (dysphonia) visualized with laryngovideostroboscopy.

Participants will receive a flexible laryngovideostroboscopy, both during normal phonation and during the specific SOVT exercise. These videos will be randomly and blindly evaluated by two experts using the Voice-Vibratory Assessment with Laryngeal Imaging (VALI) rating form (Poburka et al., 2017).

Researchers will compare the effects of these SOVT exercises on the (supra)glottic activity with the effects found in a control group producing /u/ phonation, using a randomized controlled trial.

  1. The second objective of this research is to investigate the short- and long-term effects of the three SOVT therapy approaches on the (supra)glottic activity, voice quality and self-report of patients with voice disorders (dysphonia).

Participants will receive a short-term intensive therapy with the specific SOVT exercise across four weeks.

Immediately after the therapy program and at 1 and 3 months follow-up, the voice of the participants will be re-evaluated.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Straw phonation in air
  • Behavioral: straw phonation in water
  • Behavioral: /u/ phonation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Voice Therapy With a Semi-occluded Vocal Tract: From Current Challenges to Next Level Efficacy Studies
Actual Study Start Date :
Oct 7, 2021
Actual Primary Completion Date :
Mar 14, 2023
Actual Study Completion Date :
Mar 14, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: straw phonation in air

Participants will be asked to phonate an /u/ vowel through a stirring straw in air with slightly pursed lips and a soft voice onset.

Behavioral: Straw phonation in air
Phonation (/u/ vowel) through a stirring straw (3 mm diameter, 20cm length) in air
Other Names:
  • steady SOVT exercise
  • Experimental: straw phonation in 2 cm water

    Participants will be asked to phonate an /u/ vowel through a stirring straw, placed 2 cm below the water surface, with slightly pursed lips and a soft voice onset.

    Behavioral: straw phonation in water
    Phonation (/u/ vowel) through a stirring straw (3 mm diameter, 20cm length) in 2 cm or 5 cm water
    Other Names:
  • water-resistance therapy, fluctuating SOVT exercise
  • Experimental: straw phonation in 5 cm water

    Participants will be asked to phonate an /u/ vowel through a stirring straw, placed 5 cm below the water surface, with slightly pursed lips and a soft voice onset.

    Behavioral: straw phonation in water
    Phonation (/u/ vowel) through a stirring straw (3 mm diameter, 20cm length) in 2 cm or 5 cm water
    Other Names:
  • water-resistance therapy, fluctuating SOVT exercise
  • Active Comparator: /u/ control condition

    Participants will be asked to phonate an /u/ vowel with slightly pursed lips and a soft voice onset but without a straw.

    Behavioral: /u/ phonation
    /u/ phonation without a straw, control condition
    Other Names:
  • articulatory/steady SOVT exercise
  • Outcome Measures

    Primary Outcome Measures

    1. (supra)glottic activity [baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up]

      Laryngeal function determined with the VALI form (Poburka et al., 2017)

    Secondary Outcome Measures

    1. voice quality index 1: Dysphonia Severity Index (DSI) [baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up]

      DSI: A higher index indicates a better voice quality.

    2. voice quality index 2: Acoustic Voice Quality Index (AVQI) [baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up]

      AVQI: A lower index indicates a better voice quality.

    3. self-report 1: Voice Handicap Index (VHI) [baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up]

      VHI: A lower index indicates less impact of the voice impairment on the quality of life.

    4. self-report 2: Vocal Tract Discomfort Scale (VTDS) [baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up]

      VTDS: A lower index indicates less discomfort in the vocal tract.

    5. self-report 3: Vocal Fatigue Index (VFI) [baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up]

      VFI: A lower index indicates less vocal fatigue.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Patients:

    Inclusion criteria are aged between 18 and 50 years, and diagnosed with dysphonia by an otorhinolaryngologist and SLP experienced in voice diagnostics. Exclusion criteria are previous or current participation in voice therapy, previous phonosurgical interventions, pregnancy, smoking, nasal or ear diseases, and neurological disorders.

    Vocally healthy participants:

    Inclusion criteraia are aged between 18 and 50 years. Exclusion criteria dagnosed with dysphonia, previous or current participation in voice therapy, previous phonosurgical interventions, pregnancy, smoking, nasal or ear diseases, and neurological disorders.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Rehabilitation Sciences, Ghent University (Hospital) Ghent East-Flanders Belgium 9000

    Sponsors and Collaborators

    • University Ghent
    • Research Foundation Flanders

    Investigators

    • Principal Investigator: Kristiane Van Lierde, PhD, University Ghent

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Ghent
    ClinicalTrials.gov Identifier:
    NCT06137131
    Other Study ID Numbers:
    • 249721N
    First Posted:
    Nov 18, 2023
    Last Update Posted:
    Nov 24, 2023
    Last Verified:
    Nov 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Ghent
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 24, 2023